epidemiology |
22 |
asian continental ancestry group - genetics |
15 |
systemic lupus erythematosus |
15 |
genetic predisposition to disease |
14 |
genome-wide association study |
14 |
prevalence |
13 |
allergy |
12 |
chinese |
12 |
hong kong |
12 |
antigens, cd3 - genetics |
11 |
asian |
11 |
association |
11 |
cd247 |
11 |
gwas |
11 |
lupus erythematosus, systemic - enzymology - genetics |
11 |
lupus erythematosus, systemic - genetics - immunology |
11 |
model |
11 |
all-cause pneumonia |
10 |
drug |
10 |
herd immunity |
10 |
hypersensitivity |
10 |
interrupted time series analysis |
10 |
intracellular signaling peptides and proteins - genetics |
10 |
pneumococcal conjugate vaccines |
10 |
population-based electronic health records |
10 |
bnt162b2 |
9 |
coronavac |
9 |
covid-19 |
9 |
omicron |
9 |
waning vaccine effectiveness |
9 |
lupus nephritis |
8 |
prediction |
8 |
risk assessment |
8 |
spondyloarthritis |
8 |
antibodies, antinuclear - blood |
7 |
autoantibodies |
7 |
autoantibodies - blood |
7 |
carbapenemase-producing enterobacteriaceae |
7 |
carriage |
7 |
cluster analysis |
7 |
hong kong - epidemiology |
7 |
lupus erythematosus |
7 |
lupus erythematosus, systemic - ethnology - immunology |
7 |
multivariate analysis |
7 |
nested case-control study |
7 |
risk factor |
7 |
systemic |
7 |
anaphylaxis |
6 |
cardiovascular event |
6 |
cerebrovascular event |
6 |
myocardial infarction |
6 |
prophylaxis |
6 |
stroke |
6 |
immunodeficiency |
5 |
incidence |
5 |
inflammation |
5 |
penicillin |
5 |
prevention |
5 |
rheumatology |
5 |
allergy centre |
4 |
allergy services |
4 |
ankylosing spondylitis |
4 |
antirheumatic agents |
4 |
asas criteria |
4 |
asia pacific |
4 |
axial spondyloarthritis |
4 |
basophil activation test |
4 |
cervical cancer |
4 |
corner inflammatory lesion |
4 |
diagnosis |
4 |
fungal |
4 |
modified new york criteria |
4 |
mortality |
4 |
mri |
4 |
penicillins |
4 |
pneumonia |
4 |
public health |
4 |
risk |
4 |
training |
4 |
uveitis |
4 |
age |
3 |
apparent weighted coefficient |
3 |
ascending |
3 |
crispr/cas9 |
3 |
diffusion weighted imaging |
3 |
drug allergy |
3 |
education |
3 |
expanded potential |
3 |
gain of function |
3 |
gene editing |
3 |
hereditary angioedema |
3 |
inborn errors of immunity |
3 |
janus activating kinase (jak) inhibitor |
3 |
lanadelumab |
3 |
magnetic resonance imaging |
3 |
multidisciplinary |
3 |
personalized |
3 |
phosphorylation |
3 |
predictors |
3 |
quality of life |
3 |
signal transducer and activator of transcription 1 (stat1) |
3 |
stem cell |
3 |
acinetobacter |
2 |
acute generalized exanthematous pustulosis |
2 |
adrenaline |
2 |
adrenaline autoinjector |
2 |
adult |
2 |
angioedema |
2 |
anti-bacterial agents |
2 |
antibiotics |
2 |
arthrocentesis |
2 |
asia |
2 |
atopic dermatitis |
2 |
autoantibody clusters |
2 |
autoinjector |
2 |
beta-lactam |
2 |
beta-lactams |
2 |
c1 inhibitor |
2 |
c6 |
2 |
carbapenem resistance |
2 |
case report |
2 |
chemokine (c–c motif) ligand 2 (ccl-2) |
2 |
chronic spontaneous urticaria (csu) |
2 |
clinical article |
2 |
clinical trial |
2 |
complement |
2 |
consensus |
2 |
consortium |
2 |
deficiency |
2 |
delabeling |
2 |
drug formulation |
2 |
drug hypersensitivity |
2 |
eczema |
2 |
epidemiology < systemic lupus erythematosus |
2 |
equity |
2 |
excipient allergy |
2 |
garadacimab |
2 |
human papilloma virus |
2 |
immunization |
2 |
influenza |
2 |
long-term prophylaxis |
2 |
mas-related g-protein coupled receptor-x2 (mrgprx2) |
2 |
mrgprx2 |
2 |
multidrug resistance |
2 |
non-allergist |
2 |
perioperative |
2 |
peritoneal dialysis |
2 |
peritonitis |
2 |
phenotype |
2 |
pneumococcal |
2 |
polymorphism, single nucleotide |
2 |
provocation |
2 |
safety |
2 |
small molecule antagonist |
2 |
systemic lupus erythematosus - immunological aspects. |
2 |
tryptase |
2 |
tyk2 kinase - genetics |
2 |
validation |
2 |
β-lactam |
2 |
abdominal discomfort |
1 |
acare |
1 |
allergens and epitopes |
1 |
allergist |
1 |
androgens |
1 |
anergy |
1 |
antibodies |
1 |
antibody-dependent enhancement |
1 |
asia-pacific |
1 |
asthma |
1 |
berotralstat |
1 |
bibliometric |
1 |
big data |
1 |
biologics |
1 |
bread |
1 |
burkholderia pseudomallei |
1 |
c1 esterase inhibitor |
1 |
care |
1 |
cd4 |
1 |
challenge |
1 |
chronic |
1 |
chronic rhinosinusitis |
1 |
chronic urticaria |
1 |
climate change |
1 |
cofactor |
1 |
contrast media |
1 |
corticosteroid |
1 |
covid-19 vaccines |
1 |
covid19 |
1 |
csu |
1 |
drugs |
1 |
effectiveness |
1 |
endoscopy |
1 |
excipient |
1 |
exercise-induced |
1 |
exposome |
1 |
factor xiia |
1 |
food |
1 |
food-dependent |
1 |
function |
1 |
genome |
1 |
health disparities |
1 |
helper t cell |
1 |
hereditary |
1 |
hives |
1 |
house dust mite |
1 |
icatibant |
1 |
intradermal test |
1 |
level |
1 |
lymphocytes |
1 |
macau |
1 |
melioidosis |
1 |
microbiota |
1 |
monoclonal antibody |
1 |
mycotic aneurysms |
1 |
nonallergist |
1 |
olfactory dysfunction |
1 |
opioid |
1 |
original antigenic sin |
1 |
pathway |
1 |
patient-reported outcome measures |
1 |
period |
1 |
pharmacogenetics |
1 |
pollution |
1 |
pyroglyphidae |
1 |
questionnaire |
1 |
referral |
1 |
refractory |
1 |
registry |
1 |
regulatory aspects |
1 |
research |
1 |
sars-cov-2 variants |
1 |
screening |
1 |
skin prick test |
1 |
skin testing |
1 |
skin tests |
1 |
smell |
1 |
steroid |
1 |
sublingual immunotherapy |
1 |
testing |
1 |
trends |
1 |
type 2 hae |
1 |
urticaria |
1 |
utility |
1 |
vaccine |
1 |
wheat |
1 |